baber/WOPTO huggingface dataset:
Patent JP-3495045-B2 (JP)
IPC: A61M5/145
Filed: 1995-04-24
Granted: 2004-02-09
Abstract: A liquid injection device especially suited for injecting liquid medicine into the human or animal body. The liquid injection device (10) comprises a casing (13) having a chamber (12) into which liquid is filled, a moving body (14) constituting a part of a wall of the chamber (12) and adapted to reciprocate relative to the casing (13) so as to increase or reduce the volume of the chamber (12), a cylinder (21) integrally connected either to the casing (13) or to the moving body (14), and a piston (22) axially slidably and tightly mounted on the cylinder (21), wherein an injection port (15) and a discharge port (16) both communicating with the chamber (12) are formed in the casing (13) and an enclosed cylinder chamber (23) formed by moving the piston (22) in a direction in which it moves away from the cylinder (21) is kept in a vacuum state, and wherein the moving body (14) and piston (22) are interlocked with a interlocking means (25) such that the volume of the chamber (12) is reduced in proportion to a reduction in the volume of the cylinder chamber (23). <IMAGE>
Patent JP-3727662-B2 (JP)
IPC: A21D13/00
Filed: 1997-03-04
Granted: 2005-12-14
Abstract: An improved bagel made by forming toroidal dough pieces, treating the surface of the dough pieces with a warmed acidic solution, and freezing. After storage in a frozen state, the dough pieces are thawed and baked to produce bagels at least as desirable as fresh bagels produced by conventional processes which do not use an intermediate freezing step.
Patent JP-4172034-B2 (JP)
IPC: C09C1/24
Filed: 1997-04-09
Granted: 2008-10-29
Abstract: A process for preparing an agglomerate-free suspension of nanosize iron-containing oxide particles coated in a stable manner comprises preparing an aqueous suspension of nanosize iron-containing oxide particles which are partially or completely in the form of agglomerates; adding a trialkoxysilane and a water-miscible polar organic solvent which has a boiling point at least 10° C. higher than the boiling point of water; treating the resulting suspension with ultrasound until at least 70% of the particles present are in the range of ±20% of the average particle diameter; removing the water by distillation under the action of ultrasound; and separating the non-disintegrated agglomerates.
Patent JP-3300369-B2 (JP)
IPC: A61P29/00
Filed: 1998-04-14
Granted: 2002-07-08
Abstract: The invention encompasses a process for making compounds of Formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases.
Patent AU-2001245628-B2 (AU)
Title: Immunomodulatory formulations and methods for use thereof
Inventor: NEST GARY VAN
IPC: A61K47/48
Filed: 2001-03-12
Granted: 2005-11-10
Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a nonbiodegradable microcarrier or nanocarrier.
Patent AU-2001250690-B2 (AU)
Title: A method for connection of underwater pipelines and a tool for such connection
Inventor: STORDALEN PER
IPC: F16L1/26
Filed: 2001-04-18
Granted: 2006-03-09
Abstract: A tool (1) for pulling an end (102) of a first pipe towards a stationary second pipe (100). The tool comprises gripping devices (46, 47) for securing the second pipe and winch devices (40) for pulling the tool with the pipe end towards the fixed point. A collar (50) which is attached to the stationary pipe (100) provides an anchoring point for the pull-in line. When locating the first pipe (102) directly on the stationary pipe (100), the collar (50) is advantageously equipped with an adaptor (70; 170), which comprises means for releasable attachment to the first pipe (102).
Patent AU-2001259211-B2 (AU)
Title: DNA transfection system for the generation of infectious influenza virus
Inventor: HOFFMANN ERICH
IPC: C12N15/09
Filed: 2001-04-27
Granted: 2006-07-13
Abstract: The present invention is based on the development of a dual promoter system (preferably a RNA pol I -pol II system) for the efficient intracellular synthesis of viral RNA. The resultant minimal plasmid-based system may be used to synthesize any RNA virus, preferably viruses with a negative single stranded RNA genome. The viral product of the system is produced when the plasmids of the system are introduced into a suitable host cell. One application of the system is production of attenuated, reassortant influenza viruses for use as antigens in vaccines. The reassortant viruses generated by cotransfection of plasmids may comprise genes encoding the surface glycoproteins hemagglutinin and neuraminidase from an influenza virus currently infecting the population and the internal genes from an attenuated influenza virus. An advantageous property of the present invention is its versatility; the system may be quickly and easily adapted to synthesize an attenuated version of any RNA virus. Attenuated or inactivated RNA viruses produced by the present invention may be administered to a patient in need of vaccination by any of several routes including intranasally or intramuscularly.
Patent AU-2001262957-B2 (AU)
Title: Drug combinations useful for prevention of restenosis
Inventor: FALOTICO ROBERT F
IPC: A61L31/16
Filed: 2001-04-25
Granted: 2004-12-02
Abstract: The current invention comprises an approach to solving the clinical problem of restenosis, which involves the administration of combinations of drugs to patients undergoing PTCA or stent implantation. In one embodiment of the invention, an antiproliferative agent such as rapamycin, vincristine or taxol is administered in combination with the anti-inflammatory agent, dexamethasone, to patients systemically, either subcutaneously or intravenously. In another embodiment of the invention, the antiproliferative and anti-inflammatory agents are bound in a single formulation to the surface of a stent by means of incorporation within either a biodegradeable or biostable polymeric coating. Alternatively, such drug combinations could be incorporated into a stent constructed with a grooved reservoir.
Patent AU-2001290372-B2 (AU)
Title: Transportation system
Inventor: CHAPMAN LAWRENCE HUGH
IPC: B61B13/04
Filed: 2001-09-07
Granted: 2006-07-06
Abstract: The present invention relates to an improved transportation system which includes a plurality of upright supports (1) which elevate at least one track (2). A plurality of cabs (3) are adapted to move along the track or tracks (2) provided where the cabs (3) suspended from a track (2) so that the center of mass of the cabs (3) is located below the track (2). A single track (2) provides a pair of rail elements on opposite sides of the track (2) where the first rail element is adapted to support cabs (3) moving in substantially the opposite direction to cabs (3) supported by the second rail element of the same track (2).
Patent AU-2002309928-B2 (AU)
Title: Eraser
Inventor: PINEIRO LUIS RODRIGO
IPC: C08L53/02
Filed: 2002-05-17
Granted: 2007-04-05
Abstract: An eraser composition comprising 22-41 wt % styrene-ethylene/butylene-styrene block copolymer, 5-15 wt % ethylene/propylene copolymer, 30-50 wt % calcium carbonate, 10-25 wt % factice; and 0.1-7 wt % pumice is provided. The eraser composition optionally contains up to 1 wt % titanium dioxide. The eraser composition preferably has a hardness of from 70 to 85 Shore A.
Patent AU-2002346524-B2 (AU)
Title: Implantable joint prosthesis and associated instrumentation
Inventor: KUNZLER ALEX
IPC: A61F2/00
Filed: 2002-11-26
Granted: 2007-01-18
Abstract: An implantable prosthesis is described having a pair of opposed shells and a central body disposed between the opposed shells wherein the central body and the shells cooperate to limit the motion of the central body with respect to the shells. An assembly for preparing a disc space for the implantation of a prosthesis is further described having a plurality of instruments cooperating to guide a tool associated with the assembly.
Patent AU-2003279458-B2 (AU)
Title: Security device and its production method
Inventor: SUGDON MATTHEW CHARLES
IPC: B41M3/14
Filed: 2003-11-06
Granted: 2007-08-09
Abstract: A security device comprises two or more regions (1, 2). Each region (1, 2) contains a material or combination of materials wherein the two or more regions exhibit substantially the same visible appearance under first viewing conditions and different visible appearances under second viewing conditions, the second viewing conditions. The second viewing conditions comprise a combination of a) visible light and b) substantially any UV wavelength.
Patent AU-2004200800-B2 (AU)
Title: Wrapping machine and top foil wrapping machine
Inventor: SUOLAHTI YRJO
IPC: B65B11/02
Filed: 2004-02-26
Granted: 2005-08-11
Abstract: The invention relates to a wrapping machine and/or top foil wrapping machine, comprising a machine frame (1) supported on a fixed base and comprising upright vertical columns (2); a lifting frame (3) arranged to be vertically movable upwards and downwards and guided by the vertical columns (2); a lifting motor (4) for moving the lifting frame, power transmission means for the transmission of power from the lifting motor to produce vertical motion of the lifting frame, said power transmission means comprising elongate flexible drive elements (5) and wheels for the transmission of the power of the lifting motor to the drive elements. The wrapping machine further comprises a foil dispenser (7), on which a foil web roll (8) can be rotatably supported. The top foil wrapping machine comprises a top foil depositor. The lifting motor (4) is secured to the lifting frame (3) so as to be movable with it. The wheels comprise a drive belt pulley (6) fitted for reeling a flat belt. The drive belt pulley (6) is rotatably mounted on bearings on the lifting frame (3) and rotated by the lifting motor (4). Each one of the elongate drive elements (5) consists of a drive belt whose first end (9) is secured to the upper end of the vertical columns while the second end (10) is secured to the drive belt pulley (6). <IMAGE>
Patent AU-2004207750-B2 (AU)
Title: Multi-layer effect pigment with the outermost layer having a larger thickness
Inventor: ZIMMERMANN CURTIS J
IPC: C09C1/00
Filed: 2004-01-12
Granted: 2009-05-07
Abstract: A multilayer effect pigment includes a transparent substrate, a layer of high refractive index material on the substrate, and alternating layers of low refractive index and high refractive index materials on the first layer, the total number of layers being an odd number of at least three, all adjacent layers differing in refractive index by at least about 0.2 and at least one of the layers having an optical thickness which is different from all of the other layers. The resulting multilayer effect pigment is not a quarter-wave stack. The present effect pigments may be used in cosmetic and industrial applications.
Patent AU-2004229670-B2 (AU)
Title: Method and apparatus for alignment of components of a plasma arc torch
Inventor: JONES CASEY
IPC: H05H1/34
Filed: 2004-04-09
Granted: 2008-10-09
Abstract: A coolant tube and electrode are adapted to mate with each other to align the tube relative to the electrode during operation of the torch. Improved alignment ensures an adequate flow of coolant along an interior surface of the electrode. In one aspect, an elongated body of the coolant tube has a surface adapted to mate with the electrode. In another aspect, an elongated body of the electrode has a surface adapted to mate with the coolant tube. The surfaces of the tube and electrode may, for example, be flanges, tapered surfaces, contours, or steps.
Patent AU-2004294469-B2 (AU)
Title: Method and device for cooling a steel strip
Inventor: BOUQUEGNEAU DENIS
IPC: C21D9/573
Filed: 2004-11-25
Granted: 2009-07-16
Abstract: A cooling device for tempering during continuous annealing of a flat product or metal band, preferably a steel band where the device consists of a number of symmetrically arranged horizontal tubes (1) along the band (2) along which a coolant fluid is projected across a slot or a number of holes (cavities, sic). An independent claim is included for a method of tempering during continuous annealing of a flat product or metal band.
Patent AU-2004324720-B2 (AU)
Title: Liquid transition nutrition for infants
Inventor: LUCIAN SLIWINSKI EDWARD
IPC: A23L21/25
Filed: 2004-11-12
Granted: 2011-10-27
Abstract: Liquid composition suitable for supporting the transition period wherein the infant changes from a diet consisting of breast milk or liquid infant formula to solid foods with a viscosity 20-150 mPas, containing a digestible carbohydrate fraction and an indigestible carbohydrate fraction with at least 50 wt.% soluble indigestible oligosaccharide with a degree of polymerisation (DP) between 2 and 100.
Patent AU-2005207876-B2 (AU)
Title: Rodenticide
Inventor: RAYMOND BOWMAN GARY
IPC: A01N25/00
Filed: 2005-01-07
Granted: 2011-07-14
Abstract: The invention relates to the systemic insecticide fipronil in conjunction with a rodenticide used for manufacture of a bait composition to provide a lethal effect on fleas and/or ticks and a host rodent, following ingestion of the bait composition by the host rodent. Preferred rodenticides are brodifacoum, difethialone, flocoumafen, bromadiolone and mixtures thereof. The invention also relates to rodenticidal bait compositions and to a method of killing ticks and a host rodent by providing for ingestion to the rodent, a bait composition comprising an effective amount of a rodenticide and an acaricidally effective amount of fipronil.
Patent AU-2005227420-B2 (AU)
Title: Method and compositions for altering cell function
Inventor: LYONS THOMAS PEARSE
IPC: A61K33/04
Filed: 2005-10-28
Granted: 2013-05-09
Abstract: METHODS AND COMPOSITIONS FOR ALTERING CELL FUNCTION The present invention relates to compositions and methods for altering cell function. In particular, the present invention provides compositions comprising selenium 5 (e.g., Sel-Plex) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment for neurodegenerative disease). Additionally, the present invention demonstrates that specific forms of selenium (e.g., Sel-Plex) possess the ability to alter expression of genes associated with disease and/or aging while other forms of selenium (e.g., selenomethionine) do not.
Patent AU-2005254944-B2 (AU)
Title: Polyurethane carpet backings made using fatty acid amide polyols
Inventor: JENKINES RANDALL C
IPC: C08G18/38
Filed: 2005-06-03
Granted: 2011-01-27
Abstract: Polyurethane carpet backings are made using a polyurethane-forming composition that includes fatty acid amide polyols. The formulation allows a significant replacement of conventional polyols with polyols derived from annually renewable resources, while maintaining important properties like edge curl, tuftbind, viscosity and curing rates.
Patent AU-2005267828-B2 (AU)
Title: Seal for a bearing assembly
Inventor: FAKHOURY OMAR J
IPC: E21B10/00
Filed: 2005-07-29
Granted: 2010-08-05
Abstract: A bearing assembly for a wheel assembly. In some constructions and in some aspects, the bearing assembly includes a housing defining a cavity therethrough, a first bearing cone positioned within the cavity and a second bearing cone positioned within the cavity and spaced from the first bearing cone. A first plurality of rollers is positioned between and engageable with the housing and the first bearing cone and a second plurality of rollers is positioned between and engageable with the housing and the second bearing cone. A seal seals the space between the first bearing cone and the second bearing cone. In some constructions and in some aspects, the seal is non-metallic or elastomeric.
Patent AU-2005284136-B2 (AU)
Title: Host-vector system for antibiotic-free ColE1 plasmid propagation
Inventor: REINGARD GRABHERR
IPC: C12N15/70
Filed: 2005-09-08
Granted: 2011-07-14
Abstract: A host-vector system that uses the RNA-based copy number control mechanism of ColE1-type plasmids for regulating the expression of a marker gene allows for antibiotic-free selection of plasmids and is useful for production of plasmid DNA and recombinant proteins.
Patent AU-2005288768-B2 (AU)
Title: Gland seal and corresponding assembly
Inventor: PERCEBOIS ALAIN
IPC: F16J15/12
Filed: 2005-09-21
Granted: 2011-02-24
Abstract: A composite gland sealing for the interlocking coupling of a housing end piece (8) including an anchoring groove (82), a plastic ring (14) and several locking inserts (20). Each locking insert (20) includes a radially external head (30) provided with a first front projection (50, 52) applicable against the annular front surface (90) of the anchoring groove (82). The head (30) comprises includes a second frontal projection (52, 50) radially shifted from the first front projection (50, 52).
Patent AU-2005294247-B2 (AU)
Title: Stepped cannula
Inventor: KRZYSZTOF BANKIEWICZ
IPC: A61M25/06
Filed: 2005-10-05
Granted: 2011-08-11
Abstract: Described herein are cannulas having a stepped exterior. Also described are methods of making and using these cannulas, for example to deliver one or more materials to the central nervous system of an animal.
Patent AU-2005302889-B2 (AU)
Title: Method of transmitting/receiving control information of data channel for enhanced uplink data transmission
Inventor: LEE YOUNG DAE
IPC: H04L29/08
Filed: 2005-11-09
Granted: 2009-11-26
Abstract: The present invention relates to a method of transmitting uplink control information in a wireless communication system, the method comprising generating in a user equipment (UE), a medium access control (MAC) protocol data unit (PDU) comprising control information, wherein the control information indicates an amount of resources required by the UE; and transmitting the MAC PDU to a network via an enhanced dedicated channel (E-DCH), wherein the control information is transmitted alone in the MAC PDU in connection with a specific enhanced transport format combination indicator (E-TFCI) value.
Patent AU-2005303758-B2 (AU)
Title: Compositions against SARS-coronavirus and uses thereof
Inventor: GOUDSMIT JAAP
IPC: A61K39/42
Filed: 2005-11-10
Granted: 2011-04-28
Abstract: The present invention provides compositions of binding molecules specifically binding to a coronavirus such as SARS-CoV and capable of neutralizing an infection caused by the virus. The compositions are suitable for diagnosing, preventing and/or treating a condition resulting from a coronavirus such as SARS-CoV.
Patent AU-2005315927-B2 (AU)
Title: Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them
Inventor: GERLACH UWE
IPC: A61K31/445
Filed: 2005-12-07
Granted: 2012-02-09
Abstract: The present invention relates to piperidinesulfonylureas and piperidinesulfonylthioureas of the formula (I), in which A, X, R(1), R(2) and R(3) have the meanings indicated in the claims. The compounds of the formula (I) are valuable active pharmaceutical ingredients which show in particular an inhibiting effect on ATP-sensitive potassium channels of the cardiac muscle and are suitable, for example, for the treatment of disorders of the cardiovascular system such as coronary heart disease, arrhythmias, cardiac insufficiency, cardiomyopathies or reduced contractility of the heart or for the prevention of sudden cardiac death. The invention further relates to processes for preparing the compounds of the formula (I), their use and pharmaceutical compositions comprising them.
Patent AU-2005334836-B2 (AU)
Title: Sensitization of immune system against haptenized melanoma antigens
Inventor: WESTERHOF WIETE
IPC: C12N9/99
Filed: 2005-07-28
Granted: 2012-04-12
Abstract: The invention is based on the observation that certain phenols, monophenols or benzenediols, can be metabolized into reactive quinones, in particular ortho-quinones and related reactive intermediates, which is brought about by oxidation of monophenols and benzenediols by proteins exhibiting tyrosinase activity, such as human tyrosinase and the related proteins TRP1 and TRP2. Although the substances and the produced reactive intermediates are toxic and can induce cell death, it is more relevant according to this invention that they function as haptens that become covalently bound to the tyrosinase enzymes, in particular to histidine moieties, in or near the catalytic site of proteins exhibiting tyrosinase activity, such as tyrosinase, TRP1 and TRP2. An immune response is then to be mounted against these haptenized auto-antigens, in order to treat melanocytic malignancies, in particular melanomas. This is brought about by topical administration of the phenol compounds that can function as tyrosinase substrate analogues. The invention hence provides medicaments for and methods of treating melanomas.
Patent AU-2006225071-B2 (AU)
Title: Novel potassium channel blockers and uses thereof
Inventor: HARVEY ANDREW J
IPC: A61P29/00
Filed: 2006-03-15
Granted: 2012-01-12
Abstract: The invention relates to compounds of Formula (I) for use in modulating potassium channel activity in cells.
Patent AU-2006235115-B2 (AU)
Title: Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
Inventor: HIRAWAT SAMIT
IPC: A61P7/00
Filed: 2006-04-06
Granted: 2012-07-05
Abstract: The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[l,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.
Patent AU-2006252131-B2 (AU)
Title: Hybrid plasma-cold spray method and apparatus
Inventor: DAVID HAWLEY
IPC: H05H15/00
Filed: 2006-12-19
Granted: 2011-09-29
Abstract: The present invention provides a method and apparatus of producing a dense coating with desirable stress conditions similar to coatings produced by a cold spray processes, but with higher process efficiencies and lower gas consumption. The inventive process combines features of a plasma process method of gas heating and a cold spray process to accelerate the gas, incorporating these elements into a single hybrid process. Fig. 4 Fig. 5
Patent AU-2006256825-B2 (AU)
Title: Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (L-CPT1) inhibitors
Inventor: BLEICHER KONRAD
IPC: C07C311/29
Filed: 2006-05-29
Granted: 2010-02-18
Abstract: The invention is concerned with novel sulfonamide derivatives of formula (I) wherein R2, R3, R4, A, X, Y1, Y2, Y3, Y4 and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.
Patent AU-2006266232-B2 (AU)
Title: Diaphragm latch valve
Inventor: BANIS JOSEPH K
IPC: A62C35/00
Filed: 2006-06-21
Granted: 2011-10-06
Abstract: A valve for fire suppression sprinkler systems is disclosed. The valve has a chamber with an inlet and an outlet. A closure member, positioned within the chamber, is movable to close and open the inlet. A latch engages the closure member to hold it in the closed position. The latch also engages a deformable diaphragm. The diaphragm deforms in response to pressure applied to it and allows the latch to move between a latched position engaged with the closure member and an unlatched position away from the closure member. When the diaphragm is depressurized it allows the latch to move and disengage from the closure member, which opens under fluid pressure from the inlet and allows fluid to flow through the valve.